Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale

Journal of Psychopharmacology

Volumn 29, Issue 10, 2015, Pages 1119-1128

  Montejo, Angel L ^a   Deakin, J F W ^b   Gaillard, Raphael ^c   Harmer, Catherine ^d   Meyniel, Florent ^e   Jabourian, Artin ^f   Gabriel, Cecilia ^g   Gruget, Celine ^g   Klinge, Corinna ^d   Macfayden, Christine ^d   Milligan, Holly ^b   Mullings, Emma ^b   Goodwin, Guy ^d  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d WARNEFORD HOSPITAL   (United Kingdom)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f Institut de Recherches Internationales Servier ^*  (France)

^g IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

agomelatine; antidepressant; escitalopram; healthy volunteers; Sexual dysfunction; tolerability

Indexed keywords

AGOMELATINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ESCITALOPRAM; PLACEBO; ACETAMIDE DERIVATIVE; CITALOPRAM; HYPNOTIC SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR;

ABNORMAL DREAMING; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANXIETY DISORDER; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONFERENCE PAPER; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FEMALE SEXUAL DYSFUNCTION; HEADACHE; HUMAN; MALE; MALE SEXUAL DYSFUNCTION; NAUSEA; NEUROLOGIC DISEASE; NIGHTMARE; NORMAL HUMAN; OVARY CYST; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PSYCHOTROPIC RELATED SEXUAL DYSFUNCTION QUESTIONNAIRE; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; RESTLESSNESS; RHINOPHARYNGITIS; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SOMNOLENCE; TREMOR; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VISUAL ANALOG SCALE; ADULT; CLINICAL TRIAL; DRUG EFFECTS; EMOTION; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; YOUNG ADULT;

ACETAMIDES; ADULT; CITALOPRAM; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84942104734     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115599385     Document Type: Conference Paper

References (36)

1. Abler B, Seeringer A, Hartmann A, et al. (2011) Neural correlates of antidepressant-related sexual dysfunction: A placebo-controlled fMRI study on healthy males under subchronic paroxetine and bupropion. Neuropsychopharmacol 36: 1837-1847.
2. Angst J, (1998) Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 13: S1-S4.
3. Baldwin DS, Foong T, (2013) Antidepressant drugs and sexual dysfunction. Br J Psychiatry 202: 396-397.
4. Bijlsma EY, Chan JS, Olivier B, et al. (2014) Sexual side effects of serotonergic antidepressants: Mediated by inhibition of serotonin on central dopamine release? Pharmacol Biochem Behav 121: 88-101.
5. Clayton A, Kornstein S, Prakash A, et al. (2007) Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 4: 917-929.
6. Clayton AH, Montejo AL, (2006) Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry 67: 33-37.
7. Clayton AH, Croft HA, Handiwala L, (2014) Antidepressants and sexual dysfunction: Mechanisms and clinical implications. Postgrad Med 126: 91-99.
8. Clayton AH, Pradko JF, Croft HA, et al. (2002) Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 63: 357-366.
9. Delgado PL, Brannan SK, Mallinckrodt CH, et al. (2005) Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 66: 686-692.
10. Fabre LF, Smith LC, (2012) The effect of major depression on sexual function in women. J Sex Med 9: 231-239.
11. Garcia-Portilla MP, Saiz PA, Fonseca E, et al. (2011) Psychometric properties of the Spanish version of the Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14) in patients with severe mental disorders. J Sex Med 8: 1371-1382.
12. Garnock-Jones KP, McCormack PL, (2010) Escitalopram: A review of its use in the management of major depressive disorder in adults. CNS Drugs 24: 769-796.
13. Grover S, Shah R, Dutt A, et al. (2012) Prevalence and pattern of sexual dysfunction in married females receiving antidepressants: An exploratory study. J Pharmacol Pharmacother 3: 259-265.
14. Guardiola-Lemaitre B, Bodinat C, Delagrange P, et al. (2014) Agomelatine: Mechanism of action and pharmacological profile in relation to antidepressant properties. Br J Pharmacol 171: 3604-3619.
15. Kennedy SH, Rizvi SJ, (2010) Agomelatine in the treatment of major depressive disorder: Potential for clinical effectiveness. CNS Drugs 24: 479-499.
16. Kennedy SH, Fulton KA, Bagby RM, et al. (2006) Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry 51: 234-242.
17. Kennedy SH, Ralevski E, Davis C, et al. (1996) The effects of moclobemide on sexual desire and function in healthy volunteers. Eur Neuropsychopharmacol 6: 177-181.
18. Kennedy SH, Rizvi S, Fulton K, et al. (2008) A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol 28: 329-333.
19. Kessler RC, (2003) Epidemiology of women and depression. J Affect Disord 74: 5-13.
20. Lee KU, Lee YM, Nam JM, et al. (2010) Antidepressant-induced sexual dysfunction among newer antidepressants in a naturalistic setting. Psychiatry Investig 7: 55-59.
21. Montejo AL, Garcia M, Espada M, et al. (2000) Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions. Actas Esp Psiquiatr 28: 141-150.
22. Montejo AL, Llorca G, Izquierdo JA, (1997) SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline and fluvoxamine in a prospective, multi-center and descriptive clinical study of 344 patients. J Sex Marital Ther 23: 176-184.
23. Montejo AL, Llorca G, Izquierdo JA, et al. (2001) Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. Spanish working group for the study of psychotropic-related sexual dysfunction. J Clin Psychiatry 62: 10-21.
24. Montejo AL, Perez Urdaniz P, Mosqueira I, et al. (2014) Effectiveness of switching to agomelatine in antidepressant-related sexual dysfunction. European Psychiatry 29. DOI: http://dx.doi.org/10.1016/S0924-9338(14)78858-3.
25. Montejo AL, Prieto N, Terleira A, et al. (2010) Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale. J Psychopharmacol 24: 111-120.
26. Nafziger AN, Bertino JS Jr., Goss-Bley AI, et al. (1999) Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy. J Clin Psychiatry 60: 187-190.
27. Reichenpfader U, Gartlehner G, Morgan LC, et al. (2014) Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: Results from a systematic review with network meta-analysis. Drug Saf 37: 19-31.
28. Rosen RC, Lane RM, Menza M, (1999) Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol 19: 67-85.
29. Segraves RT, Balon R, (2014) Antidepressant-induced sexual dysfunction in men. Pharmacol Biochem Behav 121: 132-137.
30. Serretti A, Chiesa A, (2009) Treatment-emergent sexual dysfunction related to antidepressants: A meta-analysis. J Clin Psychopharmacol 29: 259-266.
31. Sidi H, Asmidar D, Hod R, et al. (2012) Female sexual dysfunction in patients treated with antidepressant-comparison between escitalopram and fluoxetine. J Sex Med 9: 1392-1399.
32. Taylor D, Sparshatt A, Varma S, et al. (2014) Antidepressant efficacy of agomelatine: Meta-analysis of published and unpublished studies. BMJ 348: g1888.
33. Thakurta RG, Singh OP, Bhattacharya A, et al. (2012) Nature of sexual dysfunctions in major depressive disorder and its impact on quality of life. Indian J Psychol Med 34: 365-370.
34. Waldinger MD, Zwinderman AH, Olivier B, (2001) Antidepressants and ejaculation: A double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J Clin Psychopharmacol 21: 293-297.
35. Waldinger MD, Zwinderman AH, Olivier B, (2003) Antidepressants and ejaculation: A double-blind, randomized, fixed-dose study with mirtazapine and paroxetine. J Clin Psychopharmacol 23: 467-470.
36. Williams VS, Edin HM, Hogue SL, et al. (2010) Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: Replication in a cross-sectional patient survey. J Psychopharmacol 24: 489-496.